Cargando…

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study

Objective To quantify the risk and severity of negative effects of treatment for localised prostate cancer on long term quality of life. Design Population based, prospective cohort study with follow-up over three years. Setting New South Wales, Australia. Participants Men with localised prostate can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, David P, King, Madeleine T, Egger, Sam, Berry, Martin P, Stricker, Phillip D, Cozzi, Paul, Ward, Jeanette, O’Connell, Dianne L, Armstrong, Bruce K
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784818/ https://www.ncbi.nlm.nih.gov/pubmed/19945997 http://dx.doi.org/10.1136/bmj.b4817

Ejemplares similares

Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study
por: Mazariego, Carolyn G, et al.
Publicado: (2020)

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer
por: King, M T, et al.
Publicado: (2012)

Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study
por: Nair-Shalliker, Visalini, et al.
Publicado: (2022)

Validity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer registry data
por: Luo, Qingwei, et al.
Publicado: (2017)

Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors
por: Egger, Sam, et al.
Publicado: (2018)

Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study
por: Goldsbury, David E, et al.
Publicado: (2011)

Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data
por: Smith, David P., et al.
Publicado: (2018)

Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
por: Egger, Sam, et al.
Publicado: (2022)

Factors associated with the use of diet and the use of exercise for prostate cancer by long-term survivors
por: Hughes, Suzanne, et al.
Publicado: (2019)

Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia
por: Rodger, Jennifer C., et al.
Publicado: (2015)

Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study
por: Salagame, Usha, et al.
Publicado: (2018)

A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial
por: Brown, Bernadette, et al.
Publicado: (2018)

Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)
por: Scheinberg, Tahlia, et al.
Publicado: (2020)

New Challenges in Psycho‐Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications
por: Chambers, Suzanne K., et al.
Publicado: (2017)

Men's help‐seeking in the first year after diagnosis of localised prostate cancer
por: Hyde, M.K., et al.
Publicado: (2016)

Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case–Control Study
por: Urban, Margaret, et al.
Publicado: (2012)

Using administrative health data to describe colorectal and lung cancer care in New South Wales, Australia: a validation study
por: Goldsbury, David E, et al.
Publicado: (2012)

Patient preferences for treatment modalities for localised prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Current Trends in the Management of Localised Prostate Cancer
por: Sibley, G. N. A., et al.
Publicado: (1992)

Lung cancer treatment and mortality for Aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit
por: Gibberd, Alison, et al.
Publicado: (2016)

Proton beam therapy and localised prostate cancer: current status and controversies
por: Efstathiou, J A, et al.
Publicado: (2013)

Impact of differential cyclin D1 expression and localisation in prostate cancer
por: Comstock, C E S, et al.
Publicado: (2007)

Pros and Cons of Focal Therapy for Localised Prostate Cancer
por: Mearini, Luigi, et al.
Publicado: (2011)

The role of radiotherapy in localised and locally advanced prostate cancer
por: Bolla, Michel, et al.
Publicado: (2019)

The Localisation of the Lesions of Phthisis in Relation to Diagnosis and Prognosis
Publicado: (1888)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Pulmonary metastasis as sole manifestation of relapse in previously treated localised prostate cancer: three exceptional case reports
por: Gago, Joaquim Peres, et al.
Publicado: (2016)

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)
por: Lane, Janet Athene, et al.
Publicado: (2022)

Localised bone grafting of acetabular cysts during total hip replacement
por: Mumith, A, et al.
Publicado: (2012)

Differential proteomic alterations between localised and metastatic prostate cancer
por: Taylor, B S, et al.
Publicado: (2006)

Prognostic Value of CD1B in Localised Prostate Cancer
por: Lee, Cheng-Hsueh, et al.
Publicado: (2019)

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
por: Mukherjee, Subhabrata, et al.
Publicado: (2021)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study
por: Yu, Xue Qin, et al.
Publicado: (2017)

Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study
por: Weber, Marianne F, et al.
Publicado: (2013)

Geographic variation and localised clustering of congenital anomalies in Great Britain
por: Armstrong, Ben G, et al.
Publicado: (2007)

Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis
por: Xiong, Tengbin, et al.
Publicado: (2014)

Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study
por: Velentzis, Louiza S, et al.
Publicado: (2014)

Clinicopathological features, treatment and outcome of Omani patients with localised prostate cancer
por: Kumar, Shiyam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nvgnk2enjp18jmdbp0go27i4t1